Table of Contents

What Is Postpartum Depression?

Postpartum depression refers to depression occurring after childbirth. This form of depression is a serious but treatable medical illness that involves feelings of extreme sadness, indifference, guilt, and anxiety and often brings significant changes in energy, sleep, and thought patterns. The exact cause of postpartum depression is not known, but it is believed to be linked to physical, chemical/hormonal, social, and emotional changes that happen when having a baby.

The good news is that postpartum depression can be treated with medication and counseling, and relief may be possible. Accessing PPD treatment is essential, as postpartum depression help will support people in their recovery. When left untreated, PPD can be dangerous and negatively impact both the mother and baby.

Postpartum Depression Diagnosis

Diagnosing postpartum depression requires an assessment from a healthcare provider. It is important to be truthful and forthright during these conversations to differentiate between baby blues vs. postpartum depression, helping individuals access the treatment they need.

During PPD evaluation, the healthcare provider  will ask about symptoms and levels of severity. They will inquire about various aspects, including mood, appetite, sleep patterns, energy levels, and thoughts of self-harm. They will typically use standardized questionnaires, screening tools, and a clinical interview to help evaluate symptoms, determine the presence of PPD, and create an individualized treatment plan.

While the doctor may complete additional tests to rule out other conditions, there is no physical test used to diagnose PPD. Blood work reviews may highlight other issues contributing to the symptoms, such as low iron levels or vitamin deficiencies. Persistent feelings of depression, hopelessness, anger, and anxiety are the main diagnostic symptoms.

Psychiatric Evaluation Near You

Take Our Quick & Easy Postpartum Depression Questionnaire

Take Our Quick & Easy Postpartum Depression Questionnaire

Becoming a parent can be joyful, but it can also bring unexpected challenges. Take this assessment to identify symptoms commonly associated with postpartum depression and understand if you may be suffering from postpartum depression.
For each statement, choose the response that best describes how you have felt in the last 7 days.

"*" indicates required fields

Step 1 of 11

I have been able to laugh and see the funny side of things.
As much as I always couldNot quite so much nowDefinitely not so much nowNot at all

Therapy for Postpartum Depression

Counseling and therapy are often effective postpartum depression treatment options, helping people find alternative ways of coping with their symptoms. Therapy encourages people suffering from PPD to set realistic goals, respond to situations in positive ways, and manage challenging feelings.

Cognitive Behavioral Therapy
CBT can help new mothers manage their thoughts by identifying and changing negative patterns to make it easier to handle stress.

Interpersonal Therapy
Interpersonal therapy is a leading treatment for postpartum depression, aiming to help new mothers ease symptoms by addressing their transition into motherhood and focusing on healthy communication and relationships.

Group Therapy
Group therapy can help new mothers connect and support each other, which can help reduce feelings of isolation in early motherhood.

Couples Therapy or Family Therapy
PPD can present challenges within relationships, and couples therapy offers a structured environment in which both individuals can communicate their perspectives. This therapeutic approach addresses harmful relational patterns and provides both partners with communication strategies to support healthy self-expression.

Medication for Postpartum Depression

Postpartum Depression medication may be prescribed to ease the symptoms and support individuals as they recover. Common postpartum depression medication options include:

Antidepressants
Traditional antidepressants, including selective serotonin reuptake inhibitors (SSRIs), can help reduce the depressive symptoms present in an individual with PPD. They can improve and stabilize their mood, decrease anxiety and support them through postpartum depression. SSRIs are generally considered safe to take while breastfeeding.

Examples of SSRIs include:

These medications work by increasing the availability of serotonin in the brain, which helps improve mood and reduce depressive symptoms. Other classes of antidepressants, such as serotonin-norepinephrine reuptake inhibitors (SNRIs) or tricyclic antidepressants (TCAs), may also be considered.

A new postpartum depression treatment called Zurzuvae (zuranolone), recently FDA-approved after extensive clinical trials, is now heralded as a breakthrough. Zurzuvae (zuranolone) offers a unique mechanism of action, often providing faster relief from postpartum depression symptoms by targeting specific neuroreceptors. Its reputation for rapid onset and fewer side effects provide hope for new mothers seeking swift and efficient recovery, potentially revolutionizing postpartum depression treatment. Zurzuvae (zuranolone) is a once-daily oral medication taken for just two weeks with the expectation of quicker onset than traditional antidepressants.

Anti-anxiety Medications

Anti-anxiety medications may be used as part of a treatment plan for postpartum depression, particularly when symptoms of intense worry, agitation, or panic interfere with a new parent’s ability to function and bond with their baby. These medications aim to help by calming the overactive stress response in the brain, which can reduce physical symptoms such as racing thoughts, restlessness, and sleep disturbances, which are often heightened during the postpartum period.

Commonly prescribed options include:

  • Benzodiazepines (lorazepam or clonazepam), taken occasionally when symptoms are severe, can work quickly to ease anxiety but are used with caution due to risks of dependence and the potential for sedation in a breastfed infant.
  • Non-benzodiazepine anxiolytics (buspirone), which may be a safer long-term option than benzodiazepines without their risk of physical dependence. Caution should be used in breastfeeding individuals due to lack of long-term safety data.

Mood Stabilizers
If an individual has a history of bipolar depression, mood stabilizers such as atypical antipsychotics, lithium, or anticonvulsants like lamotrigine can provide support during this stressful period.

These medications often work best alongside therapy and support, with treatment tailored to balance maternal mental health and breastfeeding safety.

Find a Psychiatrist Near You

References:

ACOG Committee Opinion No. 757: Screening for Perinatal Depression. Obstetrics & Gynecology 132(5):p e208-e212, November 2018. | DOI:https://doi.org/10.1097/AOG.0000000000002927

Bradshaw H, Riddle JN, Salimgaraev R, Zhaunova L, Payne JL. Risk factors associated with postpartum depressive symptoms: A multinational study. J Affect Disord. 2022 Mar 15;301:345-351. doi: 10.1016/j.jad.2021.12.121. Epub 2021 Dec 31. PMID: 34979186

Carlson K, Mughal S, Azhar Y, et al. Postpartum Depression. [Updated 2024 Aug 12]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519070/

Cornett EM, Rando L, Labbé AM, Perkins W, Kaye AM, Kaye AD, Viswanath O, Urits I. Brexanolone to Treat Postpartum Depression in Adult Women. Psychopharmacol Bull. 2021 Mar 16;51(2):115-130. PMID: 34092826; PMCID: PMC8146562.

Misri, S., & Kendrick, K. (2007). Treatment of perinatal mood and anxiety disorders: A review. Canadian Journal of Psychiatry, 52(8), 489–498. https://doi.org/10.1177/070674370705200803

Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA. 2010 May 19;303(19):1961-9. doi: 10.1001/jama.2010.605. PMID: 20483973.

Stewart DE, Vigod SN. Postpartum Depression: Pathophysiology, Treatment, and Emerging Therapeutics. Annu Rev Med. 2019 Jan 27;70:183-196. doi: 10.1146/annurev-med-041217-011106. PMID: 30691372. https://pubmed.ncbi.nlm.nih.gov/30691372/

Wainwright S, Caskey R, Rodriguez A, Holicky A, Wagner-Schuman M, Glassgow AE. Screening fathers for postpartum depression in a maternal-child health clinic: a program evaluation in a midwest urban academic medical center. BMC Pregnancy Childbirth. 2023 Sep 19;23(1):675. doi: 10.1186/s12884-023-05966-y. PMID: 37726664; PMCID: PMC10508033.

photo of LifeStance provider

Clinically Reviewed By:

, MD